Avast takes $113m equity injection

 

Anti-virus maker wins big.

Anti-virus software maker Avast has received a US$100 million ($113 million) equity injection after Summit Partners took a minority stake in the firm.

Avast made a popular free anti-virus program with upgrades to premium paid versions.

The company claimed it protected "one out of every five computers around the world from malware".

It had no plans to change its distribution model, although it conceded it hadn't foreseen in the early days the level of demand it would eventually receive for its product.

"When we first launched free distribution of Avast anti-virus in the early 2000s, we gave ourselves room to grow - but never dreamed that the product would gain such global popularity," co-founder Eduard Kucera said.

Copyright © iTnews.com.au . All rights reserved.


Avast takes $113m equity injection
 
 
 
 
 
Top Stories
Vito Forte: A CIO for tough times
Fortescue Metals CIO talks vendor management and innovation.
 
Telstra shifts BigPond email to Windows Live
All data to be migrated to Microsoft cloud.
 
Vodafone Australia churn nears half a million for 2011
British joint owners 'not pleased'.
 
Sign up to receive iTnews email bulletins
   FOLLOW US...

Latest VideosSee all videos »

Latest Comments
Polls
Would you be concerned about your business' email data being hosted offshore?

   |   View results
Yes
  84%
 
No
  16%
TOTAL VOTES: 243

Vote